- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Astellas Pharma Europe BV
Total 144 results
-
Astellas Pharma Europe B.V.CompletedUrinary Bladder, OveractiveBelgium, Czech Republic, Germany, Spain, Sweden, United Kingdom
-
Astellas Pharma Europe B.V.CompletedAdvanced Prostate CarcinomaRussian Federation
-
Astellas Pharma Europe Ltd.CompletedHerpes Zoster | Herpes GenitalisFrance
-
Astellas Pharma Europe B.V.CompletedHealthy VolunteersUnited Kingdom
-
Astellas Pharma Europe B.V.CompletedVenous Thromboembolism | Arthroplasty, Replacement, HipDenmark, Spain, United States, Austria, Colombia, Russian Federation, India, Italy, United Kingdom, Germany, Hungary, Estonia, Romania, South Africa, Israel, Poland, Sweden, Canada, Australia, Lithuania, Ukraine, Latvia, Finland, Brazil, Slovak... and more
-
Astellas Pharma Europe B.V.CompletedHealthy SubjectsUnited Kingdom
-
Astellas Pharma Europe B.V.CompletedPharmacokinetics of ASP1707 | Pharmacodynamics of ASP1707France
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedOveractive Bladder | Urinary Incontinence | Urge IncontinenceFrance, Belgium, Spain, Turkey, Australia, Russian Federation, Hungary, Italy, Netherlands, Poland, Czech Republic
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Drug-Drug Interaction (DDI)France
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | EC905United Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics of ASP3652United Kingdom
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedOveractive BladderPoland, United Kingdom, Germany, Spain, Netherlands, Belgium, Czech Republic, Italy, Norway, Hungary, Sweden, Denmark, Greece, France, Russian Federation
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics of YM178Netherlands
-
Astellas Pharma Europe B.V.CompletedA Study to Find Out How YM150 is Absorbed Into and Eliminated From the Body in Healthy Male SubjectsHealthy Male Subjects | PharmacokineticsNetherlands
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedThromboembolismItaly, Spain, Sweden, Austria, Denmark, Russian Federation, Poland, Bosnia and Herzegovina, Serbia, Norway, Latvia, Finland, Lithuania, Czech Republic, Germany, Slovakia, Greece
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | Pharmacodynamics | SafetyNetherlands
-
Astellas Pharma Europe Ltd.CompletedKidney TransplantationAustralia, Austria, Belgium, Canada, Czechia, France, Germany, Greece, Hong Kong, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Philippines, Poland, Portugal, Romania, Serbia, Spain, Taiwan, Thailand, United Kingdom, Vietna...
-
Astellas Pharma Europe B.V.CompletedNeurogenic Detrusor OveractivityBelgium, Croatia, Turkey, Australia, Denmark, Israel, Jordan, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Norway, Philippines, Poland, Romania, Serbia, Slovakia, Taiwan
-
Astellas Pharma Europe B.V.CompletedOveractive Bladder | Neurogenic Detrusor OveractivityDenmark, Poland
-
Astellas Pharma Europe Ltd.Completed
-
Astellas Pharma Europe B.V.CompletedOsteoarthritis of the Knee | Chronic Lower Back PainBelgium, Czechia, Germany, Hungary, Spain, United Kingdom
-
Astellas Pharma Europe B.V.CompletedEndometriosisBelgium, Bulgaria, Germany, Hungary, Japan, Poland, Romania, Ukraine, United Kingdom
-
Astellas Pharma Europe Ltd.CompletedUrologic Diseases | Overactive Bladder | Urinary Bladder Diseases | Urgency Incontinence | Urinary Bladder OveractiveCzechia, Denmark, Greece, Ireland, Slovakia, Spain, Sweden, United Kingdom
-
Astellas Pharma Europe B.V.CompletedPediatric | Neurogenic Detrusor OveractivityUnited States, Belgium, Korea, Republic of, Philippines, Poland, United Kingdom
-
Astellas Pharma Europe B.V.CompletedType 2 Diabetes | Chronic Kidney DiseaseSpain, Czechia, Denmark, Germany, Hungary, Italy, Netherlands, Poland, United Kingdom
-
Astellas Pharma Europe B.V.CompletedType 2 Diabetes MellitusRussian Federation
-
Astellas Pharma Europe B.V.CompletedOveractive Bladder | Urgency Incontinence | Urinary Bladder Overactive | Urinary Bladder Diseases\Urologic DiseasesUnited States, Argentina, Australia, Belgium, Bulgaria, Canada, China, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Netherlands and more
-
Astellas Pharma Europe Ltd.CompletedNon-diabetic Painful Peripheral Polyneuropathy | Postherpetic Neuralgia (PHN) | Peripheral Nerve Injury (PNI)Armenia, Austria, Belarus, Belgium, Bulgaria, Czechia, Finland, France, Germany, Greece, Hungary, Italy, Poland, Portugal, Romania, Russian Federation, Slovakia, Slovenia, Spain, Sweden, Turkey, United Kingdom
-
Astellas Pharma Europe Ltd.CompletedUrologic Diseases | Urinary Bladder, Overactive | Urinary Bladder DiseasesGreece, Ireland, Armenia, Austria, Belarus, Belgium, Bulgaria, Canada, Czechia, Denmark, Finland, France, Georgia, Germany, Hungary, Italy, Kazakhstan, Latvia, Lebanon, Lithuania, Netherlands, Norway, Poland, Portugal, Russian Federation, Slovaki... and more
-
Astellas Pharma Europe B.V.CompletedNeuropathic Pain | Post-Herpetic Neuralgia (PHN) | Painful Diabetic Peripheral Neuropathy (PDPN)Czechia, Germany, Poland, United Kingdom
-
Astellas Pharma Europe B.V.Terminated
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics of ASP6294United Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy VolunteersUnited Kingdom, Germany
-
Astellas Pharma Europe B.V.TerminatedHealthy Subjects | Pharmacokinetics of ASP2205United Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy | Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia | Phase 1Netherlands
-
Astellas Pharma Europe B.V.CompletedHealthy Volunteers | Pharmacokinetics of ASP7962United Kingdom
-
Astellas Pharma Europe Ltd.TerminatedValidation | Dried Blood Spot | Transplant PatientsFrance, United Kingdom
-
Astellas Pharma Europe B.V.TerminatedClostridium DifficileFrance, Germany, Netherlands, Spain
-
Astellas Pharma Europe Ltd.CompletedPeripheral Neuropathic PainAustria, Greece, Italy, Portugal, Spain, Switzerland, United Kingdom
-
Astellas Pharma Europe B.V.CompletedPharmacokinetics of ASP8477 | Pharmacodynamics of ASP8477France, Belgium
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | Drug-Drug Interaction (DDI)Germany
-
Astellas Pharma Europe B.V.CompletedTolerability | Safety | Pharmacokinetics of ASP7962United Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | DDI (Drug-Drug Interaction)Germany
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | EC905 | Multiple DoseUnited Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | EC905United Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy SubjectsUnited Kingdom
-
Astellas Pharma Europe B.V.CompletedPharmacokinetics of ASP1707United Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics of ASP3652 | Pharmacodynamics of ASP3652United Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | Mild and Moderate Hepatic ImpairmentSlovakia
-
Astellas Pharma Europe B.V.Completed